110 Phase II clinical trial of amifostine (WR2721), cisplatin (C), vinblastine (V) (ACV) and thoracic radiation therapy (RT) for unresectable stage III non small cell lung cancer (NSCLC). Article

Tannehill, S, Mehta, M, Larson, M et al. (1995). 110 Phase II clinical trial of amifostine (WR2721), cisplatin (C), vinblastine (V) (ACV) and thoracic radiation therapy (RT) for unresectable stage III non small cell lung cancer (NSCLC). . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 32 196. 10.1016/0360-3016(95)97775-v

cited authors

  • Tannehill, S; Mehta, M; Larson, M; Storer, B; Schiller, J; Kinsella, T

authors

publication date

  • January 1, 1995

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Lung
  • Lung Cancer
  • Radiation Oncology

Digital Object Identifier (DOI)

publisher

  • Elsevier

start page

  • 196

volume

  • 32